Logo image of ALT

ALTIMMUNE INC (ALT) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:ALT - US02155H2004 - Common Stock

5.28 USD
+0.01 (+0.19%)
Last: 12/15/2025, 8:00:00 PM
5.31 USD
+0.03 (+0.57%)
After Hours: 12/15/2025, 8:00:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to ALT. ALT was compared to 529 industry peers in the Biotechnology industry. The financial health of ALT is average, but there are quite some concerns on its profitability. While showing a medium growth rate, ALT is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ALT had negative earnings in the past year.
ALT had a negative operating cash flow in the past year.
In the past 5 years ALT always reported negative net income.
In the past 5 years ALT always reported negative operating cash flow.
ALT Yearly Net Income VS EBIT VS OCF VS FCFALT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M -100M

1.2 Ratios

ALT has a better Return On Assets (-38.41%) than 60.30% of its industry peers.
ALT has a Return On Equity of -45.21%. This is in the better half of the industry: ALT outperforms 68.05% of its industry peers.
Industry RankSector Rank
ROA -38.41%
ROE -45.21%
ROIC N/A
ROA(3y)-50.39%
ROA(5y)-43.11%
ROE(3y)-56.08%
ROE(5y)-47.74%
ROIC(3y)N/A
ROIC(5y)N/A
ALT Yearly ROA, ROE, ROICALT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80 -100

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ALT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ALT Yearly Profit, Operating, Gross MarginsALT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200K -400K

More info and screens

5

2. Health

2.1 Basic Checks

ALT does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ALT has been increased compared to 1 year ago.
ALT has more shares outstanding than it did 5 years ago.
There is no outstanding debt for ALT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ALT Yearly Shares OutstandingALT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
ALT Yearly Total Debt VS Total AssetsALT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

ALT has an Altman-Z score of 5.80. This indicates that ALT is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 5.80, ALT is doing good in the industry, outperforming 73.72% of the companies in the same industry.
A Debt/Equity ratio of 0.08 indicates that ALT is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.08, ALT is doing worse than 62.76% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Altman-Z 5.8
ROIC/WACCN/A
WACC8.83%
ALT Yearly LT Debt VS Equity VS FCFALT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

A Current Ratio of 17.18 indicates that ALT has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 17.18, ALT belongs to the top of the industry, outperforming 93.76% of the companies in the same industry.
ALT has a Quick Ratio of 17.18. This indicates that ALT is financially healthy and has no problem in meeting its short term obligations.
ALT has a Quick ratio of 17.18. This is amongst the best in the industry. ALT outperforms 93.76% of its industry peers.
Industry RankSector Rank
Current Ratio 17.18
Quick Ratio 17.18
ALT Yearly Current Assets VS Current LiabilitesALT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

4

3. Growth

3.1 Past

ALT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 20.15%, which is quite impressive.
The Revenue for ALT has decreased by -61.54% in the past year. This is quite bad
Measured over the past years, ALT shows a very negative growth in Revenue. The Revenue has been decreasing by -67.82% on average per year.
EPS 1Y (TTM)20.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%34.38%
Revenue 1Y (TTM)-61.54%
Revenue growth 3Y-83.45%
Revenue growth 5Y-67.82%
Sales Q2Q%0%

3.2 Future

ALT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 38.08% yearly.
Based on estimates for the next years, ALT will show a very strong growth in Revenue. The Revenue will grow by 889.71% on average per year.
EPS Next Y25.7%
EPS Next 2Y3.94%
EPS Next 3Y6.78%
EPS Next 5Y38.08%
Revenue Next Year0%
Revenue Next 2Y0%
Revenue Next 3Y1667.5%
Revenue Next 5Y889.71%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALT Yearly Revenue VS EstimatesALT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 500M 1B 1.5B
ALT Yearly EPS VS EstimatesALT Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 20 -20 -40 -60 -80

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ALT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALT Price Earnings VS Forward Price EarningsALT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALT Per share dataALT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y3.94%
EPS Next 3Y6.78%

More info and screens

0

5. Dividend

5.1 Amount

ALT does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

ALTIMMUNE INC

NASDAQ:ALT (12/15/2025, 8:00:00 PM)

After market: 5.31 +0.03 (+0.57%)

5.28

+0.01 (+0.19%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-06 2025-11-06/bmo
Earnings (Next)02-25 2026-02-25/amc
Inst Owners40.48%
Inst Owner Change6.65%
Ins Owners0.62%
Ins Owner Change0.33%
Market Cap550.44M
Revenue(TTM)20.00K
Net Income(TTM)-83.92M
Analysts78.57
Price Target18.93 (258.52%)
Short Float %22.48%
Short Ratio7.9
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)21.69%
Min EPS beat(2)17.24%
Max EPS beat(2)26.14%
EPS beat(4)4
Avg EPS beat(4)18.17%
Min EPS beat(4)0.21%
Max EPS beat(4)29.11%
EPS beat(8)7
Avg EPS beat(8)14.31%
EPS beat(12)11
Avg EPS beat(12)15.65%
EPS beat(16)15
Avg EPS beat(16)15.29%
Revenue beat(2)2
Avg Revenue beat(2)296.04%
Min Revenue beat(2)296.04%
Max Revenue beat(2)296.04%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.6%
PT rev (3m)0.6%
EPS NQ rev (1m)3.4%
EPS NQ rev (3m)21%
EPS NY rev (1m)11.28%
EPS NY rev (3m)11.67%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-11.19%
Revenue NY rev (3m)-10.07%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 27522
P/FCF N/A
P/OCF N/A
P/B 2.97
P/tB 2.97
EV/EBITDA N/A
EPS(TTM)-1.07
EYN/A
EPS(NY)-1.23
Fwd EYN/A
FCF(TTM)-0.64
FCFYN/A
OCF(TTM)-0.64
OCFYN/A
SpS0
BVpS1.78
TBVpS1.78
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -38.41%
ROE -45.21%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-50.39%
ROA(5y)-43.11%
ROE(3y)-56.08%
ROE(5y)-47.74%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 17.18
Quick Ratio 17.18
Altman-Z 5.8
F-Score3
WACC8.83%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%34.38%
EPS Next Y25.7%
EPS Next 2Y3.94%
EPS Next 3Y6.78%
EPS Next 5Y38.08%
Revenue 1Y (TTM)-61.54%
Revenue growth 3Y-83.45%
Revenue growth 5Y-67.82%
Sales Q2Q%0%
Revenue Next Year0%
Revenue Next 2Y0%
Revenue Next 3Y1667.5%
Revenue Next 5Y889.71%
EBIT growth 1Y9.09%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year5.52%
EBIT Next 3Y-9.37%
EBIT Next 5Y14.09%
FCF growth 1Y13.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y13.37%
OCF growth 3YN/A
OCF growth 5YN/A

ALTIMMUNE INC / ALT FAQ

What is the ChartMill fundamental rating of ALTIMMUNE INC (ALT) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ALT.


Can you provide the valuation status for ALTIMMUNE INC?

ChartMill assigns a valuation rating of 0 / 10 to ALTIMMUNE INC (ALT). This can be considered as Overvalued.


Can you provide the profitability details for ALTIMMUNE INC?

ALTIMMUNE INC (ALT) has a profitability rating of 1 / 10.


Can you provide the financial health for ALT stock?

The financial health rating of ALTIMMUNE INC (ALT) is 5 / 10.


What is the earnings growth outlook for ALTIMMUNE INC?

The Earnings per Share (EPS) of ALTIMMUNE INC (ALT) is expected to grow by 25.7% in the next year.